Related Experiment Video

Updated: Apr 5, 2026

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

3.5K

Small nuclear ribonucleoprotein associated polypeptide N accelerates cell proliferation in pancreatic adenocarcinoma

Jin Ma1, Zhuo Zhang2, Jiancheng Wang2

  • 1Department of Gastroenterology, The Affiliated Ruijin Hospital Lu Wan Branch of Medical College, Shanghai Jiao Tong University, Shanghai 200020, P.R. China.

Molecular Medicine Reports
|August 12, 2015
PubMed

Insights

Small nuclear ribonucleoprotein associated polypeptide N (SNRPN) is vital for pancreatic cancer cell growth. Disrupting SNRPN in pancreatic adenocarcinoma cells inhibited proliferation, induced cell cycle arrest, and promoted apoptosis, suggesting SNRPN as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The spliceosome, a complex RNA-protein machinery, is essential for pre-mRNA splicing and implicated in various cancers.
  • While spliceosome involvement in cancer is recognized, its specific role in pancreatic adenocarcinoma is not well understood.
  • SNRPN is a critical component of the spliceosome, but its function in pancreatic cancer remains to be elucidated.

Purpose of the Study:

  • To investigate the role of SNRPN in pancreatic adenocarcinoma.
  • To determine the effect of SNRPN disruption on pancreatic cancer cell behavior.
  • To explore SNRPN as a potential therapeutic target for pancreatic cancer.

Main Methods:

  • Lentivirus-mediated RNA interference (RNAi) was used to deplete SNRPN in BxPC-3 pancreatic adenocarcinoma cells.
  • Cell proliferation was assessed using the MTT assay.
  • Cell cycle progression and apoptosis were analyzed via cell cycle analysis.

Main Results:

  • Knockdown of SNRPN significantly reduced the proliferation of BxPC-3 cells.
  • SNRPN depletion impaired colony formation in pancreatic adenocarcinoma cells.
  • Loss of SNRPN induced S phase cell cycle arrest and apoptosis in cancer cells.

Conclusions:

  • SNRPN plays a crucial role in the growth and survival of pancreatic adenocarcinoma cells.
  • Targeted inhibition or disruption of SNRPN may represent a promising therapeutic strategy for pancreatic cancer.
  • Further research into SNRPN's function could lead to novel treatments for pancreatic adenocarcinoma.

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay10:29

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay

Published on: April 14, 2014

10.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.7K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K